Increased serum levels of soluble tumor necrosis factor receptors (sTNF-Rs) in children and adolescents with vertically and horizontally transmitted HIV infection
Authors:
- 1 July 1996
- journal article
- research article
- Published by Springer Nature in Infection
- Vol. 24 (4) , 301-308
Abstract
Two different receptors exist for tumor necrosis factor-α (TNF-α), designated as p55 (TNF-RI) and p75 (TNF-RII). Soluble (= s) forms of TNF-Rs are secreted after proteolytic cleavage and block the effects of TNF-α. sTNF-RI, sTNF-RII and the soluble interleukin 2 receptor (sIL-2R) were determined by ELISA in serum samples of HIV-infected children and adolescents. Twelve children with vertical HIV infection (mean age ± SD, 5.9±3.8 years) and 17 horizontally infected patients (16.1±7.3 years) were classified according to the revised CDC criteria. Twenty healthy control persons (6.4±5.8 years) showed the following receptor concentrations (median): sTNF-RI 888 pg/ml, sTNF-RII 1,741 pg/ml, sIL-2R 94 pM. Compared to controls, horizontally HIV-infected patients had significantly (Mann-Whitney U test) higher levels for sTNF-RI (median 1,192 pg/ml), sTNF-RII (3,481 pg/ml) and sIL-2R (128 pM). For vertically infected children only sTNF-RII (2,944 pg/ml) was significantly elevated compared to controls. There were no differences in soluble receptor levels between vertical or horizontal transmission. Surprisingly, no significant differences for sTNF-RI, sTNF-RII and sIL-2R occurred when 19 patients in stage CDC I were compared to ten patients in stages II or III. The clearly elevated sTNF-RII levels in patients with horizontal and vertical HIV infection indicate the activation of the monocyte/macrophage system in both groups. Für den Tumor-Nekrose-Faktor-α (TNF-α) sind zwei als p55 (TNF-RI) und p75 (TNF-RII) bezeichnete Rezeptoren bekannt. Lösliche Komponenten der TNF-Rs werden durch proteolytische Spaltung freigesetzt und blockieren die Wirkungen von TNF-α. Wir bestimmten sTNF-RI, sTNF-RII und den löslichen Interleukin 2-Rezeptor (sIL-2R) mit Enzymimmunoassays in Serumproben von HIV-infizierten Kindern und Jugendlichen. Zwölf Kinder mit vertikaler HIV-Infektion (mittleres Alter ± SD, 5,9±3,8 Jahre) und 17 horizontal infizierte Patienten (16,1±7,3 Jahre) wurden nach den revidierten CDC-Kriterien klassifiziert. Zwanzig gesunde Kontrollpersonen (6,4±5,8 Jahre) wiesen die folgenden Rezeptor-Konzentrationen (Median) auf: sTNF-RI 888 pg/ml, sTNF-RII 1741 pg/ml, sIL-2R 94 pM. Gegenüber Kontrollen zeigten horizontal HIV-Infizierte im Mann-Whitney U-Test signifikant höhere Werte für sTNF-RI (Median 1192 pg/ml), sTNF-RII (3481 pg/ml) und sIL-2R (128 pM). Bei vertikal Infizierten lagen nur die sTNF-RII-Spiegel (2944 pg/ml) signifikant höher als bei den Kontrollen. Zwischen horizontal und vertikal Infizierten bestanden keine signifikanten Unterschiede für die löslichen Rezeptoren. Auch beim Vergleich der HIV-Stadien (19 × CDC I versus 10 × CDC II/III) ergaben sich überraschend keine signifikanten Differenzen für sTNF-RI, sTNF-RII und sIL-2R. Die deutliche Erhöhung von sTNF-RII-Spiegeln bei Patienten mit horizontaler und vertikaler HIV-Infektion weist auf die Aktivierung des Monozyten-Makrophagen-Systems in beiden Gruppen hin.Keywords
This publication has 55 references indexed in Scilit:
- Soluble tumor necrosis factor receptors in febrile neutropenic cancer patientsInfection, 1995
- Activation of tumor necrosis factor — α system in HIV-1 infection: Association with markers of immune activationInfection, 1995
- Soluble tumour necrosis factor receptors (sTNF-R) and HIV infection: correlation to CD8+ lymphocytesClinical and Experimental Immunology, 1993
- Age-Adjusted CD4+ Lymphocyte Parameters in Healthy Children at Risk for Infection with the Human Immunodeficiency VirusClinical Infectious Diseases, 1993
- Age-related standards for T lymphocyte subsets based on uninfected children born to human immunodeficiency virus 1-infected women*The Pediatric Infectious Disease Journal, 1992
- Elevated serum levels of soluble tumour necrosis factor receptors (sTNF-R) in patients with HIV infectionClinical and Experimental Immunology, 1992
- Two TNF receptorsImmunology Today, 1992
- AUGMENTATION OF IN-VITRO HIV REPLICATION IN PERIPHERAL BLOOD MONONUCLEAR CELLS OF AIDS AND ARC PATIENTS BY TUMOUR NECROSIS FACTORThe Lancet, 1989
- Purified blood monocytes from HIV 1-infected patients induce high levels of TNFα and IL-1Clinical Immunology and Immunopathology, 1989
- The Human Immunodeficiency Virus: Infectivity and Mechanisms of PathogenesisScience, 1988